{"title":"Predictive modeling approaches for Alzheimer's disease diagnosis through neuroimaging techniques","authors":"Kamlesh Kumar Pandey , Abhay Mishra , Ram Milan","doi":"10.1016/j.arr.2025.102989","DOIUrl":null,"url":null,"abstract":"<div><div>Alzheimer's disease (AD) is one of the brain's neurodegenerative diseases. It is distinguished by a progressive mental, social, and behavioral deterioration. It affects the person's capacity, thinking, attention, reasoning, social behavior and functionality to achieve independence. The classical diagnosis process of AD consists of variety of neuroimaging scan approaches such as computerized tomography, magnetic resonance imaging and positron emission tomography. Classical cerebrospinal fluid biomarkers such as amyloid-β₄₂, total tau, and phosphorylated tau are used in conjunction with neuroimaging to diagnose Alzheimer’s disease. Biomarkers are used inside of neuro scan images to measure the brain's structure and functions such as brain cortical thinning, brain atrophy and glucose metabolism. The Classical cerebrospinal fluid biomarkers such as amyloid-β₄₂, total tau, and phosphorylated tau are used in conjunction with neuroimaging to diagnose Alzheimer’s disease. The classical diagnosis processes identified Alzheimer's disease through the manual manipulation of biomarkers in neuroimages. Therefore, the classical AD diagnosis processes suffer from time, cost and accuracy-related challenges. Machine learning and deep learning are the rising predictive modeling techniques that automatically diagnose AD with high accuracy and minimum time. The predictive modeling avoids manual manipulation of biomarkers and combines the processes of neuro scans and biomarkers. The integration of artificial intelligence with AD diagnoses addresses prevailing technological challenges in problem-solving and decision support. This study details and discusses the predictive modeling process and principal components with respect to the AD diagnosis process. The predictive model emphasizes the significance of diverse machine learning and deep learning algorithms. The predictive model utilized neuroimaging techniques, biomarker identification, features and data management, preprocessing, ML and DL algorithms, data sets, and performance matrices. This study also analyzes various classical predictive models and determines the performance level of the classifier, preprocessing steps, dataset, and validation metrics.</div></div>","PeriodicalId":55545,"journal":{"name":"Ageing Research Reviews","volume":"114 ","pages":"Article 102989"},"PeriodicalIF":15.5000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ageing Research Reviews","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1568163725003356","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/12/8 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Alzheimer's disease (AD) is one of the brain's neurodegenerative diseases. It is distinguished by a progressive mental, social, and behavioral deterioration. It affects the person's capacity, thinking, attention, reasoning, social behavior and functionality to achieve independence. The classical diagnosis process of AD consists of variety of neuroimaging scan approaches such as computerized tomography, magnetic resonance imaging and positron emission tomography. Classical cerebrospinal fluid biomarkers such as amyloid-β₄₂, total tau, and phosphorylated tau are used in conjunction with neuroimaging to diagnose Alzheimer’s disease. Biomarkers are used inside of neuro scan images to measure the brain's structure and functions such as brain cortical thinning, brain atrophy and glucose metabolism. The Classical cerebrospinal fluid biomarkers such as amyloid-β₄₂, total tau, and phosphorylated tau are used in conjunction with neuroimaging to diagnose Alzheimer’s disease. The classical diagnosis processes identified Alzheimer's disease through the manual manipulation of biomarkers in neuroimages. Therefore, the classical AD diagnosis processes suffer from time, cost and accuracy-related challenges. Machine learning and deep learning are the rising predictive modeling techniques that automatically diagnose AD with high accuracy and minimum time. The predictive modeling avoids manual manipulation of biomarkers and combines the processes of neuro scans and biomarkers. The integration of artificial intelligence with AD diagnoses addresses prevailing technological challenges in problem-solving and decision support. This study details and discusses the predictive modeling process and principal components with respect to the AD diagnosis process. The predictive model emphasizes the significance of diverse machine learning and deep learning algorithms. The predictive model utilized neuroimaging techniques, biomarker identification, features and data management, preprocessing, ML and DL algorithms, data sets, and performance matrices. This study also analyzes various classical predictive models and determines the performance level of the classifier, preprocessing steps, dataset, and validation metrics.
期刊介绍:
With the rise in average human life expectancy, the impact of ageing and age-related diseases on our society has become increasingly significant. Ageing research is now a focal point for numerous laboratories, encompassing leaders in genetics, molecular and cellular biology, biochemistry, and behavior. Ageing Research Reviews (ARR) serves as a cornerstone in this field, addressing emerging trends.
ARR aims to fill a substantial gap by providing critical reviews and viewpoints on evolving discoveries concerning the mechanisms of ageing and age-related diseases. The rapid progress in understanding the mechanisms controlling cellular proliferation, differentiation, and survival is unveiling new insights into the regulation of ageing. From telomerase to stem cells, and from energy to oxyradical metabolism, we are witnessing an exciting era in the multidisciplinary field of ageing research.
The journal explores the cellular and molecular foundations of interventions that extend lifespan, such as caloric restriction. It identifies the underpinnings of manipulations that extend lifespan, shedding light on novel approaches for preventing age-related diseases. ARR publishes articles on focused topics selected from the expansive field of ageing research, with a particular emphasis on the cellular and molecular mechanisms of the aging process. This includes age-related diseases like cancer, cardiovascular disease, diabetes, and neurodegenerative disorders. The journal also covers applications of basic ageing research to lifespan extension and disease prevention, offering a comprehensive platform for advancing our understanding of this critical field.